Evidence map›Paper›PMID 39014029›Full record

ArticleAIDS and behavior2024

Correlates of Intimate Partner Violence, Including Psychological Partner Violence, in a Multisite U.S. Cohort of People in HIV Care.

R J Fredericksen, L S Mixson, L N Drumright, R M Nance, J A C Delaney, S A Ruderman, B M Whitney, A Hahn, J Ma, K H Mayer and 10 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS and behavior, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

R J FredericksenDepartment of Medicine, University of Washington, Seattle, WA, USA. rfrederi@uw.edu.ORCID http://orcid.org/0000-0003-3936-7048
L S MixsonDepartment of Medicine, University of Washington, Seattle, WA, USA.
L N DrumrightDepartment of Medicine, University of Washington, Seattle, WA, USA.
R M NanceDepartment of Medicine, University of Washington, Seattle, WA, USA.
J A C DelaneyDepartment of Medicine, University of Washington, Seattle, WA, USA.
S A RudermanDepartment of Medicine, University of Washington, Seattle, WA, USA.
B M WhitneyDepartment of Medicine, University of Washington, Seattle, WA, USA.
A HahnDepartment of Medicine, University of Washington, Seattle, WA, USA.
J MaDepartment of Medicine, University of Washington, Seattle, WA, USA.
K H MayerFenway Institute, Boston, MA, USA.
K A ChristopoulosDepartment of Medicine, University of California, San Francisco, CA, USA.
A L WilligDepartment of Medicine, University of Alabama, Birmingham, AL, USA.
S NapravnikUniversity of North Carolina, Chapel Hill, NC, USA.
L BamfordUniversity of California, San Diego, CA, USA.
E CachayUniversity of California, San Diego, CA, USA.
J J EronUniversity of North Carolina, Chapel Hill, NC, USA.
M SaagDepartment of Medicine, University of Alabama, Birmingham, AL, USA.
J JacobsonCase Western Reserve University, Cleveland, OH, USA.
M M KitahataDepartment of Medicine, University of Washington, Seattle, WA, USA.
H M CraneDepartment of Medicine, University of Washington, Seattle, WA, USA.

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Latesha Ellen Elopre · 1988 to 2026
$84.1M
Substance use patterns and contexts: impact on epigenetic age and prevention strategies in an HIV clinical care cohortR01DA047045 · NIDA · UNIVERSITY OF WASHINGTON · PI Heidi M. Crane, Joseph Austin Delaney · 2018 to 2026
$5.1M
HIV and Substance Use Cohort Coordinating Center for Emerging and High Impact Scientific Cross Cohort Studies: HIV SUCCESSU24DA058307 · NIDA · UNIVERSITY OF WASHINGTON · PI GEETANJALI CHANDER, Heidi M. Crane · 2023 to 2026
$3.6M
Understanding Health Inequities at the Intersection of the HIV and substance use epidemics across racial/ethnic and other underserved populationsR01DA058938 · NIDA · UNIVERSITY OF WASHINGTON · PI Heidi M. Crane, Rob Fredericksen · 2023 to 2026
$2.8M
Implementation and Evaluation of psPRO: Person-specific Patient-Reported Outcome Assessments for Patients in HIV Care living with Multiple Chronic ConditionsU18HS026154 · AHRQ · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., LOBER, WILLIAM B · 2019 to 2021
$1.2M
AHRQ HHS U18 HS026154AHRQ HHS U18HS026154Intramural Research Program, National Institute on Drug Abuse R01DA058938Intramural Research Program, National Institute on Drug Abuse U24DA058307National Institute of Allergy and Infectious Diseases AI027767NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI027767NIAID NIH HHS R24 AI067039NIDA NIH HHS R01 DA047045NIDA NIH HHS R01DA047045NIDA NIH HHS R01 DA058938
6 · The paper itself

Abstract

We examined past-year intimate partner violence (IPV), including psychological violence without physical/sexual violence, and health outcomes among people with HIV (PWH) in care in a multi-site U.S. cohort. Between 2016 and 2022, PWH reported 12-month psychological, physical, and sexual IPV in a routine assessment. We used linear and logistic regression models adjusted for age, race/ethnicity, and site to examine relationships with health outcomes. Among 9748 PWH (median age 50 years, 81% cisgender male/16% cisgender female/1% transgender female; 44% non-Hispanic white/36% non-Hispanic Black/15% Hispanic), 9.3% (n = 905) reported any IPV in the past 12 months; half reported psychological IPV without physical/sexual IPV (n = 453). PWH reporting any type of IPV were on average younger than those who did not experience IPV. In adjusted models, any IPV was associated with increased likelihood of unstable housing, HIV viral load detection (HIV viral load ≥ 75 copies/mL), moderate-to-severe depressive symptoms, anxiety with panic symptoms, substance use (methamphetamines, cocaine/crack, illicit opioids, marijuana, heavy episodic/hazardous drinking), and concern about exposure to sexually transmitted infection. PWH reporting any IPV in the past 12 months had 4.2% lower adherence to antiretroviral therapy, 2.4 more HIV-related symptoms, a 1.9 point higher HIV stigma score, and a 9.5% lower quality of life score than those without IPV. We found similar associations among PWH reporting only psychological IPV, without physical/sexual IPV. IPV was common among PWH. Half reporting IPV reported only psychological IPV and had similarly poor outcomes as those reporting physical/sexual IPV, demonstrating the need to assess psychological as well as physical and sexual IPV.

Indexed as

HIV InfectionsIntimate Partner ViolenceAdultCohort StudiesDepressionFemaleHumansMaleMiddle AgedRisk FactorsSexual PartnersUnited StatesViral LoadVIHViolencia de la pareja íntimaViolencia psicológica de pareja

Identifiers

PMID39014029
PMCPMC11390320

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.